INITIAL PSA >=1.5 NG/ML IN MEN = < 50 YEARS OLD PREDICTS A SUBSEQUENT HIGHER RISK OF PROSTATE CANCER

被引：0
|
作者：
Uhlman, Matthew
Tang, Ping
Sun, Leon
Robertson, Cary
Polascik, Thomas
Albala, David
Donatucci, Craig
Moul, Judd
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1572
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页码：E666 / E666
页数：1
相关论文
共 50 条
  • [21] Utility of PSA doubling time (PSADT) in the detection of prostate cancer in men with a serum PSA ≤ 10 ng/ml
    Spurgeon, S
    Garzotto, M
    Collins, L
    Priest, R
    Hsieh, YC
    Peters, L
    Beer, TM
    Mori, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 414S - 414S
  • [22] PROSTATE CANCER INCIDENCE AND DISEASE-SPECIFIC SURVIVAL IN MEN PARTICIPATING IN THE ERSPC WITH AN INITIAL PSA UNDER 3.0 NG/ML
    Bul, M.
    Van Leeuwen, P. J.
    Zhu, X.
    Schroder, F. H.
    Roobol, M. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 145 - 145
  • [23] Outcome of prostate cancer patients with initial PSA≥ 20 ng/ml undergoing radical prostatectomy
    Zweryel, Ulrike
    Suttmann, Henrik
    Schroeder, Thomas
    Siemer, Stefan
    Wullich, Bernd
    Kamradt, Joern
    Lehmann, Jan
    Stoeckle, Michael
    EUROPEAN UROLOGY, 2007, 52 (04) : 1058 - 1066
  • [24] Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10 ng/mL
    Hsieh, Po-Fan
    Chang, Chao-Hsiang
    Yang, Chi-Rei
    Huang, Chi-Ping
    Chen, Wen-Chi
    Yeh, Chin-Chung
    Chou, Eric Chieh-Lung
    Chen, Kuo-Liang
    Lien, Chi-Shun
    Chen, Guang-Heng
    Hsiao, Po-Jen
    Chang, Yi-Huei
    Wu, Hsi-Chin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2018, 34 (08): : 461 - 466
  • [25] An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care
    Crawford, E. David
    Rosenberg, Matt T.
    Partin, Alan W.
    Cooperberg, Matthew R.
    Maccini, Michael
    Loeb, Stacy
    Pettaway, Curtis A.
    Shore, Neal D.
    Arangua, Paul
    Hoenemeyer, John
    Leveridge, Mike
    Leapman, Michael
    Pinto, Peter
    Thompson, Ian M., Jr.
    Carroll, Peter
    Eastham, James
    Gomella, Leonard
    Klein, Eric A.
    UROLOGY, 2016, 96 : 116 - 120
  • [26] Reduced PSAV threshold is predictive of prostate cancer in men with serum PSA <4 ng/ml
    Nature Clinical Practice Urology, 2008, 5 (2): : 62 - 63
  • [27] The Chances of Subsequent Cancer Detection in Patients with a PSA &gt; 20 ng/ml and an Initial Negative Biopsy
    Shaida, N.
    Jones, C.
    Ravindranath, N.
    Malone, P. R.
    THESCIENTIFICWORLDJOURNAL, 2009, 9 : 343 - 348
  • [28] Free/Total PSA Ratio: Predictive Value in Auguring Prostate Cancer Occurrence in African Men with Initial PSA Levels of 2.0 to 4.0 ng/ml
    Abbar, M.
    Janane, A.
    Ismail, Ould T.
    Ghadouane, M.
    Ameur, A.
    UROLOGY, 2012, 80 (03) : S295 - S295
  • [29] Evaluation of prostate cancer risk in men with PSA &lt; 1.5.
    Stanton, Whitney N.
    Crawford, E. David
    Arangua, Paul
    Hoenemeyer, John
    La Rosa, Francisco G.
    van Bokhoven, Adrie
    Lucia, M. Scott
    Poage, Wendy
    Werahera, Priya N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 64 - U3
  • [30] THE RISK OF BEING DIAGNOSED WITH POTENTIALLY INCURABLE PROSTATE CANCER IN MEN WITH PSA 1-3 NG/ML IS NOT RELATED TO THE RATIO OF FREE PSA
    Carlsson, S.
    Aus, G.
    Hugosson, J.
    Lilja, H.
    Pihl, C. G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 163 - 163
12345